Quality of life assessment (QoL) In the group with partial tumor regression, the KPS showed nearly significant improvement from 62.5 ± 17 to 80 ± 8 ( P , 0.068).
← all excerpts
Concomitant <sup>177</sup>Lu-DOTATATE and capecitabine therapy in malignant paragangliomas.
1
—
—